Donna Harrison, M.D.is a board-certified obstetrician and gynecologist and Executive Director of the American Association of Prolife Obstetricians and Gynecologists (www.aaplog.org). AAPLOG is the largest pro-life physician organization in the world, and was recognized as a special interest group within the American College (Congress) of Obstetrics and Gynecology (ACOG) for over 40 years from 1973 to 2013, until ACOG discontinued the use of the term “special interest group” within the Congress.
Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, abortion long term morbidity, and medical abortion.
She has lectured extensively as a continuing medical education speaker in the United States and internationally on topics of medical abortion with mifepristone and misoprostol, adverse events associated with mifepristone and misoprostol, emergency contraception with ulipristal, maternal mortality and the association with abortion, and post abortion short- and long-term complications. She is an adjunct professor at Trinity International University in Deerfield, IL, recently teaching a postgraduate continuing medical education seminar on current reproductive technologies ethical implications. She has authored peer-reviewed papers on the RU-486 approval process, adverse events associated with medical abortion with mifepristone and misoprostol, and mechanisms of action of ulipristal.
She has also spoken before the FDA Reproductive Health Advisory Committees on mifepristone and ulipristal and has addressed numerous congressional committees, as well as presenting at the United Nations Committee on the Status of Women accessory sessions on topics related to medical abortion in developing nations, and maternal mortality and abortion.